Political Quotes

“I appreciate the opportunity to present this amendment. This amendment would delay the implementation of the MAT Act, section 262, until January of 2024. Currently, the Act would eliminate the patient cap on the number of patients a single healthcare provider can provide buprenorphine to. This cap was created originally in 2000 in the Drug Addiction Treatment Act, which initially set the cap at 30 patients. Since 2000, the cap has been increased several times, and the current law is 275 patients per healthcare practitioner. This patient cap has never been lifted before or even studied as to what the effects would be if it was lifted. This is a complex treatment area. Patients don't just need buprenorphine, or its less addictive form known by the trade name Suboxone. They need behavioral healthcare treatment. They need hands-on, detailed guidance. They need to do a long, step-down process, slowly reducing and then eliminating all of the opioids that they are using or have used. Buprenorphine is also an opioid. It is better than heroin or fentanyl, and it can be used as a treatment very effectively. But it still can be addictive. There are reports of its sale on the street. With no cap on the number of patients, I fear we could see abuse.…”